Jeff Galvin, CEO of Addimmune, sits down with David Weisburd to discuss cell and gene therapy, and how Addimmune is working on a functional solution for HIV. We’re proudly sponsored by Bidav Insurance Group, visit lux-str.com if you’re ready to level up your insurance plans.

(0:00) Episode Preview

(2:21) Jeff’s background

(5:08) Teaching at MIT as a teenager

(8:22) What is gene therapy?

(11:53) Episode Sponsor: Bidav Insurance Group

(12:39) Gene therapy success stories

(16:11) What is HIV?

(20:14) AGT103 and the quest for a functional HIV cure

(23:22) AGT103’s Phase I results

(29:43) How gene therapy could revolutionize pharmaceuticals

(30:52) How to contact Addimmune